You are here

  1. Home
    2. »
  2. Professional resources
    3. »
  3. News
    4. »
  4. Treatment
    5. »
  5. 2016
    6. »
  6. February 2016

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

05 February 2016
Analysis
Truvada - the drug used as PrEP

Analysis: Tenofovir resistance ‘surprisingly common’

Resistance to the commonly prescribed antiretroviral drug tenofovir is ‘surprisingly common’, according to findings published in the Lancet Infectious Diseases last week. 

Read more